1. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
    Tomasz Kostrzewski et al, 2017, WJG CrossRef
  2. In vivo analysis at the cellular level reveals similar steatosis induction in both hepatitis C virus genotype 1 and 3 infections
    B. Campana et al, 2017, J Viral Hepat CrossRef
  3. Metformin impairs systemic bile acid homeostasis through regulating SIRT1 protein levels
    Qi Chen et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  4. Adipose differentiation-related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation
    Haomin Zhao et al, 2017 CrossRef
  5. Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
    Charlotte J. Green et al, 2018, Diabetes Obes Metab CrossRef
  6. Development of a fatty liver model using oleic acid in primary liver cells isolated from Atlantic salmon and the prevention of lipid accumulation using metformin
    Marit Espe et al, 2019, Aquacult Nutr CrossRef
  7. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
    Samir Rouabhia et al, 2014, Expert Review of Gastroenterology & Hepatology CrossRef
  8. The therapy of insulin resistance in other diseases besides type 2 diabetes
    Laura Pala et al, 2014, Eat Weight Disord CrossRef
  9. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis
    Hong Xu et al, 2016 CrossRef
  10. Polychlorinated biphenyls exposure-induced insulin resistance is mediated by lipid droplet enlargement through Fsp27
    Hye Young Kim et al, 2017, Arch Toxicol CrossRef
  11. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
    Kunal Maniar et al, 2017, Pharmacological Research CrossRef
  12. Therapeutic effect of treatment with metformin and/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease
    Selene de Jesús Acosta-Cota et al, 2019, European Journal of Pharmacology CrossRef
  13. Metformin reduces lipid accumulation in HepG2 cells via downregulation of miR-33b
    Mina Zare et al, 2019, Archives of Physiology and Biochemistry CrossRef
  14. The level of 1C diets fed prior to cell isolation affects lipid metabolism in primary liver cells isolated from Atlantic salmon ( Salmo salar )
    Marit Espe et al, 2020, Aquacult Nutr CrossRef
  15. The relation between serum adipose differentiation-related protein and non-alcoholic fatty liver disease in type 2 diabetes mellitus
    Huaying Fan et al, 2020, Therapeutic Advances in Endocrinology CrossRef
  16. Expression pattern of perilipins in human brain during aging and in Alzheimer's disease
    Maria Conte et al, 2021, Neuropathol Appl Neurobiol CrossRef
  17. Analytical and Omics-Based Advances in the Study of Drug-Induced Liver Injury
    Thomas Kralj et al, 2021 CrossRef
  18. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis
    Szu-Wei Huang et al, 2021, Lipids Health Dis CrossRef
  19. Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients
    Berkan Kurt et al, 2021, Biomedicines CrossRef
  20. A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
    Elaine Chow et al, 2022, Pharmaceuticals CrossRef
  21. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
    Qian-Long Wu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
  22. Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet
    Gerard Baiges-Gaya et al, 2022, Biomolecules CrossRef
  23. Elevated adipose differentiation‐related protein level in ovariectomized mice correlates with tissue‐specific regulation of estrogen
    Jing Zhu et al, 2023, J of Obstet and Gynaecol CrossRef
  24. Discovering cellular programs of intrinsic and extrinsic drivers of metabolic traits using LipocyteProfiler
    Samantha Laber et al, 2023, Cell Genomics CrossRef